Education
About Us
Working with TipRanks
Follow Us
BioVaxys Technology (TSE:BIOV)
:BIOV
BIOV Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.02 - C$0.08
Previous CloseN/A
Volume0.00
Average Volume (3M)199.43K
Market Cap
$7.29M
Enterprise ValueC$8.78M
Total Cash (Recent Filing)$4.31K
Total Debt (Recent Filing)$133.72K
Price to Earnings (P/E)―
Beta0.51
Next Earnings
Sep 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding291,525,200
10 Day Avg. Volume92,856
30 Day Avg. Volume199,433
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.20
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-2.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioVaxys Technology News
BIOV FAQ
What was BioVaxys Technology’s price range in the past 12 months?
BioVaxys Technology lowest stock price was C$0.02 and its highest was C$0.08 in the past 12 months.
What is BioVaxys Technology’s market cap?
BioVaxys Technology’s market cap is $7.29M.
When is BioVaxys Technology’s upcoming earnings report date?
BioVaxys Technology’s upcoming earnings report date is Sep 26, 2025 which is in 40 days.
How were BioVaxys Technology’s earnings last quarter?
BioVaxys Technology released its earnings results on Jun 30, 2025. The company reported -C$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.005.
Is BioVaxys Technology overvalued?
According to Wall Street analysts BioVaxys Technology’s price is currently Overvalued.
Does BioVaxys Technology pay dividends?
BioVaxys Technology does not currently pay dividends.
What is BioVaxys Technology’s EPS estimate?
BioVaxys Technology’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioVaxys Technology have?
BioVaxys Technology has 291,525,200 shares outstanding.
What happened to BioVaxys Technology’s price movement after its last earnings report?
BioVaxys Technology reported an EPS of -C$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 14.286%.
Which hedge fund is a major shareholder of BioVaxys Technology?
Currently, no hedge funds are holding shares in TSE:BIOV
Company Description
BioVaxys Technology
BioVaxys Technology Corp. is a biotechnology company focused on developing viral and oncology vaccines as well as immuno-diagnostics. Operating in the life sciences sector, BioVaxys leverages its proprietary haptenization technology platform to create vaccines designed to elicit a robust immune response. The company is engaged in the development of vaccines for SARS-CoV-2, as well as therapeutic vaccines for ovarian cancer and other solid tumors.
Technical Analysis
Ownership Overview
10.05% Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
89.95% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---